By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



35 Ehad Ha-Am Street

  Tel-Aviv  65202   Israel
Phone: n/a Fax: n/a


Company News
Alcobra (ADHD) CEO To Step Down, Effective May 31, 2017 5/15/2017 6:32:25 AM
Alcobra (ADHD) Mails Proxy Materials For Extraordinary General Meeting Of Shareholders 4/24/2017 11:39:06 AM
Alcobra (ADHD) Provides Update On Request For Extraordinary General Meeting 4/5/2017 11:23:43 AM
Alcobra (ADHD) To Host Investor Forum And Webcast On March 28 In New York City 3/1/2017 11:16:05 AM
Alcobra (ADHD) Announces Fourth-Quarter And Full-Year 2016 Financial Results And Provides Corporate Update 2/15/2017 8:22:08 AM
Alcobra (ADHD) Reports On Productive FDA Meeting For New Lead Product Candidate For ADHD 2/7/2017 11:11:47 AM
Alcobra (ADHD) Release: Company Stock Decimated As ADHD Drug Flunks Phase III Test 1/17/2017 5:34:55 AM
Alcobra (ADHD) Provides Update On Recent FDA Meeting And Path Forward For MDX Clinical Development Program 1/9/2017 7:17:50 AM
Alcobra (ADHD) Updates On Recent FDA Meeting 12/14/2016 6:56:41 AM
Alcobra (ADHD) Announces Third Quarter 2016 Financial Results And Provides Corporate Update 11/15/2016 9:14:48 AM